CAS 1246817-49-1

Ticlopidine-d4

Description:

Ticlopidine-d4 is a deuterated form of ticlopidine, which is an antiplatelet medication primarily used to reduce the risk of stroke and other cardiovascular events. The "d4" designation indicates that four hydrogen atoms in the ticlopidine molecule have been replaced with deuterium, a stable isotope of hydrogen. This modification can enhance the compound's stability and alter its pharmacokinetic properties, making it useful in research applications, particularly in studies involving drug metabolism and pharmacodynamics. Ticlopidine-d4 retains the core structure and biological activity of ticlopidine, which functions by inhibiting platelet aggregation through the blockade of ADP receptors on platelets. The compound is typically characterized by its molecular formula, mass spectrometry, and NMR spectroscopy, which can confirm the presence of deuterium. As a research chemical, ticlopidine-d4 is often utilized in clinical studies and analytical chemistry to trace the metabolic pathways of ticlopidine and to improve the understanding of its therapeutic effects and potential side effects.

Formula: C₁₄H₁₄ClNS

Synonyms:

• Tiklyd-d4
• Ticlid-d4
• Ticlopidine-d4
• 5-[(2-Chlorophenyl)Methyl]-4,5,6,7-tetrahydro-thieno[3,2-c]pyridine-d4
• 5-[(2-chloro-3,4,5,6-tetradeuteriophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine
• PCR 5332-d4

Ticlopidine-d4 HCl

CAS: 1246817-49-1

Formula: C₁₄H₁₀D₄ClNS·HCl

Color and Shape: White To Off-White Solid

Molecular weight: 267.81 36.46

Ref: 4Z-T-502

Ticlopidine-d4

Controlled Product

CAS: 1246817-49-1

Applications An antithrombotic. A platelet aggregation inhibitor.
References Leblonde, G., : Biochem. Pharmacol., 27, 2099 (1978), O’Brien, J.R., et al: Thromb. Res., 13, 245 (1978), Katsumura, T., et al.: Angiology, 33, 357 (1982),

Formula: C₁₄₂H₄H₁₀ClNS

Color and Shape: Neat

Molecular weight: 267.81

Ref: TR-T438327